Next up for CRISPR: Gene editing for the masses?
Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.
Continue Reading![](https://s0.storage.snapzu.com/favicons/t/e/c/h/www.technologyreview.com.png)
Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.
Continue Reading
Join the Discussion